We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.9B
1-Year Est. Return 121.13%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
+121.13%
3 Year Est. Return
+281.43%
5 Year Est. Return
+350.91%
10 Year Est. Return
–
AUM
$1.9B
AUM Growth
-$88M
Cap. Flow
+$2.36M
Cap. Flow %
0.12%
Top 10 Hldgs %
47.92%
Holding
151
New
44
Increased
37
Reduced
36
Closed
31

Top Buys

Rank Stock Value
1
BKD icon
Brookdale Senior Living
BKD
+$44.7M
2
WELL icon
Welltower
WELL
+$35.8M
3
DOC icon
Healthpeak Properties
DOC
+$33.9M
4
ABVX
Abivax
ABVX
+$32.7M
5
OHI icon
Omega Healthcare
OHI
+$26.7M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$48.5M
2
DHR icon
Danaher
DHR
+$42.6M
3
VERA icon
Vera Therapeutics
VERA
+$38.7M
4
VRDN icon
Viridian Therapeutics
VRDN
+$31.7M
5
BRKR icon
Bruker
BRKR
+$27.9M

Sector Composition

Rank Sector Weight
1 Healthcare 74.35%
2 Real Estate 5.59%
3 Financials 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVMN
101
Evommune Inc
EVMN
$409M
$1.26M 0.07%
+54,680
New +$1.24M
IMCR icon
102
Immunocore
IMCR
$1.78B
$1.18M 0.06%
+39,238
New +$1.27M
ASMB icon
103
Assembly Biosciences
ASMB
$506M
$1.13M 0.06%
40,889
-118,787
-74% -$3.39M
PLRX icon
104
Pliant Therapeutics
PLRX
$67.5M
$1.12M 0.06%
891,425
+49,402
+6% +$62.4K
SPRY icon
105
ARS Pharmaceuticals
SPRY
$590M
$1.09M 0.06%
136,235
-115,358
-46% -$1.11M
WHWK
106
Whitehawk Therapeutics
WHWK
$183M
$1.06M 0.06%
306,800
+46,541
+18% +$146K
TYRA icon
107
Tyra Biosciences
TYRA
$1.82B
$1.04M 0.05%
27,055
-251,509
-90% -$8.14M
PASG icon
108
Passage Bio
PASG
$15.9M
$1.03M 0.05%
131,581
+5,351
+4% +$55.4K
DHC
109
Diversified Healthcare Trust
DHC
$2.26B
$1M 0.05%
+151,283
New +$959K
INMD icon
110
InMode
INMD
$872M
$927K 0.05%
67,744
+5,806
+9% +$82.8K
SNDA icon
111
Sonida Senior Living
SNDA
$1.97B
$917K 0.05%
+28,437
New +$951K
BCYC
112
Bicycle Therapeutics
BCYC
$270M
$885K 0.05%
190,715
+11,800
+7% +$67.4K
EDIT icon
113
Editas Medicine
EDIT
$399M
$719K 0.04%
290,919
– –
SSII
114
SS Innovations International
SSII
$696M
$551K 0.03%
110,157
+34,799
+46% +$167K
REPL icon
115
CALL
Replimune Group
REPL
$814M
$398K 0.02%
+52,000
New +$397K
RVP icon
116
Retractable Technologies
RVP
$20.4M
$384K 0.02%
580,919
– –
EHTH icon
117
eHealth
EHTH
$42.5M
$285K 0.02%
220,915
-1,655
-0.7% -$3.83K
SLQT icon
118
SelectQuote
SLQT
$114M
$225K 0.01%
357,661
– –
AIRS icon
119
AirSculpt Technologies
AIRS
$325M
$210K 0.01%
+74,139
New +$173K
KPTI icon
120
CALL
Karyopharm Therapeutics
KPTI
$168M
$133K 0.01%
+23,800
New +$181K
ACAD icon
121
Acadia Pharmaceuticals
ACAD
$4.25B
– –
-176,594
Closed -$4.72M
ASND icon
122
Ascendis Pharma A/S
ASND
$16.7B
– –
-48,241
Closed -$10.3M
BHVN icon
123
Biohaven
BHVN
$2.16B
– –
-145,431
Closed -$1.64M
BIIB icon
124
Biogen
BIIB
$29.9B
– –
-77,944
Closed -$13.7M
BMY icon
125
Bristol-Myers Squibb
BMY
$127B
– –
-235,293
Closed -$12.7M
3 4
5
6 7

Similar funds

DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $1.89B AUM 14.55% 1-Year Est. Return
OPCM
Osborne Partners Capital Management San Francisco, California $1.89B AUM 16.21% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
RCA
Resonant Capital Advisors Madison, Wisconsin $1.9B AUM 14.38% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return

Eversept Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Eversept Partners held 151 positions worth $1.9B, down 4.4% from $1.98B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Eversept Partners's Q1 2026 filing shows 44 new, 37 increased, 36 reduced and 31 closed positions. Its largest new stake was Welltower: 180,953 shares worth $35.8M. The largest sale was GSK, an estimated $48.5M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 90% a quarter earlier, followed by Real Estate and Financials.

  • Eversept Partners's largest Q1 2026 buy was Welltower: 180,953 shares worth $35.8M.
  • Eversept Partners added most to Brookdale Senior Living in Q1 2026, an estimated $44.7M increase.
  • Eversept Partners's biggest Q1 2026 reduction was GSK, cutting an estimated $48.5M.
  • Eversept Partners fully exited Danaher in Q1 2026, selling an estimated $42.6M.
  • Eversept Partners's ten largest holdings make up 48% of its $1.9B portfolio in Q1 2026.
  • Eversept Partners opened 44 new positions and closed 31 in Q1 2026.
  • Eversept Partners's portfolio value fell 4.4% quarter-over-quarter to $1.9B.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.